62.1 percent given doses surprisingly 90 percent subset participants followed scientists puzzled possible reasons result speculate linked longer interval doses half dose group according astrazeneca spokesperson exploratory analysis found vaccine efficacy 73 percent single dose dose interval 22 days 12 weeks u.k. doses given interval 12 weeks data participants immune response showed antibodies increased second dose longer interval doses preliminary data unpublished suggest increased immune response longer dosing intervals result increased efficacy company spokesperson says not surprising says shane crotty professor la jolla institute immunology center infectious disease vaccine research booster immunization given day 21 days 28 days 12 weeks